LEADER 02018nam  2200445z- 450 
001 9910557565503321
005 20231214133510.0
035   $a(CKB)5400000000043972
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/74376
035   $a(EXLCZ)995400000000043972
100   $a20202111d2020      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEvidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer
210   $cFrontiers Media SA$d2020
215   $a1 electronic resource (207 p.)
311   $a2-88966-247-0 
330   $aThis eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
606   $aScience: general issues$2bicssc
606   $aPharmacology$2bicssc
610   $aEvidence-based
610   $aimmunotherapy
610   $acancer
610   $aadverse event
610   $amanagement
615  7$aScience: general issues
615  7$aPharmacology
700   $aZhang$b Yonggang$4edt$01330023
702   $aMa$b Xuelei$4edt
702   $aZhou$b Shuang$4edt
702   $aZhang$b Yonggang$4oth
702   $aMa$b Xuelei$4oth
702   $aZhou$b Shuang$4oth
906   $aBOOK
912   $a9910557565503321
996   $aEvidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer$93039698
997   $aUNINA